26A-1121027
USP filing
The present invention provides a fully-automated system for intelligent continuous manufacturing that can operate in a negative pressure environment and be applied to pathogen research and detection, including but not limited to virus, bacteria, fungi, etc. It can also operate in a positive pressure environment and be applied to antibody production and cell therapy production (e.g., therapeutic cells, stem cells, or CAR-T (Chimeric Antigen Receptor T) cells). The automated system of the present invention can be controlled and monitored by software to achieve more efficient operations and management.
The automated apparatus has the following advantages:
Enables highly efficient and precise operation, reducing personnel operation time and risk.
Enhances the consistency and reproducibility of operations.
Ensures the cleanliness and safety of the experimental environment.
Automatically disinfects the apparatus, ensuring hygiene.
Automatically transports the apparatus, improving transportation efficiency.
Enables interaction with AI, enabling more efficient operation and management.
Enables the handle RG3 and RG4 pathogens under negative pressure.
Enables to produce therapeutic cells or stem cells or CART cells vice versa in positive pressure.
This invention covers an automated apparatus that can be applied to the research and detection of various pathogens, including but not limited to virus, bacteria, and fungi. Furthermore, this invention can apply in automated producing cell therapy products and immunological antibodies. This invention also covers the use of various software to control and monitor the automated apparatus, enabling more efficient operations and management.
Jung-Hsin Lin
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

A method and combination for intelligent manufacturing and operation